Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Health Educ Behav. 2010 Aug;37(4):504–532. doi: 10.1177/1090198109357319

Cognitive Behavioral Theories Used to Explain Injection Risk Behavior Among Injection Drug Users: A Review and Suggestions for the Integration of Cognitive and Environmental Models

Karla D Wagner 1, Jennifer B Unger 2, Ricky N Bluthenthal 3, Valentina A Andreeva 4, Mary Ann Pentz 5
PMCID: PMC3084153  NIHMSID: NIHMS240747  PMID: 20705809

Abstract

Injection drug users (IDUs) are at risk for HIV and viral hepatitis, and risky injection behavior persists despite decades of intervention. Cognitive behavioral theories (CBT) are commonly used to help understand risky injection behavior. We review findings from CBT-based studies of injection risk behavior among IDUs. An extensive literature search was conducted in Spring 2007. In total 33 studies were reviewed—26 epidemiological and 7 intervention studies. Findings suggest that some theoretical constructs have received fairly consistent support (e.g., self-efficacy, social norms), while others have yielded inconsistent or null results (e.g., perceived susceptibility, knowledge, behavioral intentions, perceived barriers, perceived benefits, response efficacy, perceived severity). We offer some possible explanations for these inconsistent findings, including differences in theoretical constructs and measures across studies and a need to examine the environmental structures that influence risky behaviors. Greater integration of CBT with a risk environment perspective may yield more conclusive findings and more effective interventions in the future.

Keywords: HIV risk behavior, injection drug use, Cognitive Behavioral Theory, literature review

I. Prevalence of Injection Risk Behavior

There are approximately 13 million injection drug users (IDUs) in the world (Aceijas et al., 2004), and IDUs are at risk for a number of negative health outcomes including infection with Human Immunodeficiency Virus (HIV; Centers for Disease Control and Prevention, 2006), and hepatitis C virus (HCV; Centers for Disease Control and Prevention, 1998). Though HIV incidence rates among IDUs in the United States have declined in recent years, (Des Jarlais & Semaan, 2008; Santibanez et al., 2006) injection risk behavior remains an important vector for new infections. For HCV, injection-related risks for transmission are considerable; the majority of new injectors seroconvert to HCV-positive status within 5 years of injection initiation (Garfein et al., 2004; Miller et al., 2002; Miller et al., 2009). With no effective vaccines in production for either HIV or HCV, the need to better understand the predictors of risky injection practices in order to develop more effective interventions persists.

Decreases in risky injection behavior among IDUs, particularly in receptive syringe sharing, have been observed since the beginning of the HIV epidemic in the U.S. (e.g., Des Jarlais et al., 2000; Mehta et al., 2006). Despite these significant declines, risky injection behavior has continued. For example, in the most recent National HIV Behavioral Surveillance System (NHBS) survey of IDUs in 23 U.S. cities, 32% reported sharing syringes, and 33% reported sharing other injection paraphernalia (Centers for Disease Control and Prevention, 2009). A recent study of young out-of-treatment IDUs in five U.S. cities found that 53% of participants reported receptive syringe sharing (Thiede et al., 2007). Among those who did not share syringes, 59% reported other unsafe injection practices such as paraphernalia (i.e., cookers, cotton, or rinse water) sharing or syringe-mediated drug splitting. In another recent sample of syringe exchange program (SEP) participants, up to 38% of IDUs reported receptive syringe sharing and up to 62% reported paraphernalia sharing, with odds of sharing increasing as access to safe injection supplies decreased (Bluthenthal et al., 2007).

Behavioral interventions have demonstrated some success in reducing risk injection practices. Some of the earliest interventions took place within the context of the National Institute on Drug Abuse-funded National AIDS Demonstration Research (NADR) and Cooperative Agreement (CA) projects. Implemented from 1987 through the late 1990’s, the NADR/CA interventions demonstrated significant reductions in frequency of injection and receptive syringe and paraphernalia sharing, and increases in needle disinfection and entry into drug treatment (Coyle et al., 1998). In most NADR/CA projects, both enhanced and standard intervention participants significantly reduced risk behaviors. A review of 19 psychosocial interventions implemented during a similar time period (1990 – 1998) found four without serious design limitations that demonstrated significant intervention effects (Gibson et al., 1998). The effective interventions were characterized by intensive and sustained interventions with stable and motivated participants. More recently, a meta-analysis of 49 randomized controlled trials conducted from 1991 to 2004 found that behavioral interventions had more effect on changing some behaviors (e.g., frequency of injection drug use and entry into drug treatment) than others (e.g., syringe sharing; Copenhaver et al., 2006). In a more recent behavioral intervention trial for young IDUs conducted from 2002 to 2004, both the experimental and control conditions significantly reduced injection risk behavior at follow-up (Garfein et al., 2007). While individual measures of injection risk behavior (i.e., receptive syringe sharing, syringe mediated drug splitting, number of injection partners, and sharing cookers, cotton, or water) did not differ significantly between conditions, an overall composite score created from the six risk behavior items did achieve statistical significance – there was a 29% greater decline in overall injection risk among the participants in the experimental condition compared to the control condition. Many of these interventions were theoretically-based and generally report on their ultimate behavioral outcomes, but far less is known about which constructs are responsible for intervention success and which predict continued risk behavior. Further, the NHBS reports that only 27% of IDUs in 23 U.S. cities reported participating in an HIV behavioral intervention, suggesting that the reach of these interventions is still limited (Centers for Disease Control and Prevention, 2009).

Structural interventions, too, have yielded reductions in risk behavior (Blankenship et al., 2006), and researchers are increasingly focusing on the “risk environment” in which risky injection occurs (Rhodes, 2002). One structural intervention that has been particularly effective in reducing risky injection practices is the provision of sterile injection supplies via SEPs (Ksobiech, 2003). In areas that have adopted this intervention, SEPs have dramatically improved the ability of IDUs to access sterile syringes and may be responsible for observed declines in injection risk behavior and HIV infection (MacDonald et al., 2003). Still, many IDUs do not have sufficient syringes to meet their daily needs and continue to share syringes and other injection paraphernalia (Bluthenthal et al., 2007). Therefore, the need for more effective and widespread prevention interventions for IDUs remains, even among those with access to SEPs (Des Jarlais et al., 2007b; Santibanez et al., 2006).

II. Cognitive Behavioral Theories Used to Explain Injection Risk

Cognitive behavioral theories (CBTs) - focused on properties of the individual - are among the most commonly employed frameworks in the health research and intervention literature (Glanz et al., 1997), including the literature on risky injection behavior (Gibson et al., 1998), and are frequently used as the basis for behavioral intervention design. Among those most frequently used to explain risky injection practices among IDUs are the Health Belief Model (HBM; Strecher & Rosenstock, 1997), the Theory of Reasoned Action (TRA) and its successor the Theory of Planned Behavior (TPB; Ajzen, 1991), Social Learning Theory/Social Cognitive Theory (SLT/SCT; Bandura, 1986) and Protection Motivation Theory (PMT; Rogers, 1983). Additionally, newer theories have been developed specifically to explain HIV-related risk behavior, drawing largely from other CBTs: the stage-based AIDS Risk Reduction Model (ARRM; Catania et al., 1990); the Information, Motivation, Behavioral Skills (IMB) model (Fisher & Fisher, 1992); and Fishbein’s Integrated Model of HIV Risk Behavior (Fishbein, 2000). As has been discussed by others, these theories of health behavior share many constructs and in many cases differ primarily in their operationalization of the constructs and the hypothesized relationships between them (Bandura, 2004; Wallston & Wallston, 1984).

This literature review aims to describe existing findings regarding the influence of constructs from CBTs on injection risk behavior, and to identify areas in need of further research. For this paper, we define injection risk behavior as use of a needle/syringe, cooker, cotton or mix/rinse water that had been previously used by another drug injector. It is likely that a combined approach that integrates both cognitive and environmental models may have the highest probability of eliminating the “residual risk behaviors” (Des Jarlais et al., 2007b) that persist even in the presence of existing intervention schemes (Metzger & Navaline, 2003). We will suggest that a theoretical perspective that integrates individual-level constructs with a measure of environmental correlates of injection risk behavior may provide insight into the persistence of injection risk behavior and provide a basis for the development of interventions that simultaneously address both cognitive and environmental determinants of behavior.

III. Methods

Selection of studies

An extensive literature search was conducted using the online databases PubMed (1950 – 2007) and PsychINFO (1806 – 2007) in Spring, 2007. In the initial search, each Cognitive Behavioral Theory (i.e., Health Belief Model, Protection Motivation Theory, Theory of Reasoned Action, Theory of Planned Behavior, Social Cognitive Theory, Social Learning Theory, AIDS Risk Reduction Model, and Information Motivation Behavioral Skills) was crossed one-at-a-time with each of four terms: injection drug use, HIV, needle/syringe sharing, and intervention. This search strategy yielded 445 hits. Results were limited to articles published in English, studies that identified injection risk behavior (syringe or paraphernalia sharing) as an outcome, and studies that explicitly measured cognitive behavioral constructs. Studies among injection drug users examining only sexual risk behavior and those that were theoretically based without measuring specific constructs were excluded. These exclusion criteria significantly reduced the number of relevant studies; from the initial search, 44 studies were retained.

Upon initial review of the search results, it was evident that this strategy omitted several important studies that, while they employed various theoretical constructs, did not specifically mention the theoretical underpinnings of the study. Rather than consign these studies to the category of “atheoretical” and exclude them from the review, we conducted another search in which the individual theoretical constructs (i.e., self-efficacy, response efficacy, outcome expectancies, outcome expectations, attitudes, perceived severity, perceived seriousness, perceived risk, perceived susceptibility, perceived vulnerability, social norms, knowledge, emotional coping, behavioral skills, behavioral intentions) were crossed with needle/syringe sharing, yielding an additional 249 hits. Again, studies examining only sexual risk behavior and those not published in English were excluded. Fifty-six studies were retained from this second search, yielding a total of 100 studies. Strictly qualitative studies, duplicative findings, studies that did not identify injection risk behavior as the outcome (e.g., studies that identified changes in knowledge or behavioral intentions as the only outcome), and intervention studies that did not examine theoretical mediators were eliminated. In total 33 studies were reviewed – 26 epidemiological and 7 intervention studies. It is important to note that the search strategy yielded several other important intervention studies, however only those reporting specifically on the theoretical mediators were included in this review.

IV. Results – Evidence to Support Cognitive Behavioral Theories of Injection Risk Behavior

Study participants and design

Epidemiological and intervention studies of injection risk behavior employing constructs from CBTs are described in Tables 1 and 2. Sixteen epidemiological studies were conducted in the U.S. or Puerto Rico, while ten were conducted abroad, in areas including: Canada, Hungary, Pakistan, Ireland, Scotland, Thailand, India, Australia, and the Netherlands. Of the 26 epidemiological studies, fifteen were conducted exclusively with not-in-treatment IDUs who were recruited using street-based or agency-based outreach, seven were conducted in drug treatment settings (e.g., methadone maintenance programs (MMP) or detoxification programs), and four combined recruitment locations. One study specifically recruited HIV-positive IDUs, while two restricted enrollment to HIV-negative participants and two restricted enrollment to HCV-negative participants. Two studies enrolled only women, and two studies enrolled only men. The majority of studies used a cross-sectional or observational design (20/26), while six studies employed a longitudinal design with follow-up periods ranging from 4 to 12 months. Data were collected via self-report instruments that were generally interviewer-administered.

Table 1.

Epidemiological studies using cognitive behavioral theories or theoretical constructs to examine injection risk behavior.

Study Year Sample Theoretical
Foundation
Theoretical Constructs Main Drug-related
Outcome
Significant Findings Related to
Theoretical Constructs of Interest
Cox et al. 2008 N=321 IDUs in
Montreal,
Canada
(70% male,
mean age 33
years)
ARRM HCV knowledge
Severity
Susceptibility/vulnerability
Peer norms
Benefits
Barriers
Self-efficacy for risk reduction
Self-efficacy to convince others to
reduce risk
SS, PS SS associated with:
-Difficulty injecting safely due to lack
of equipment (+)
-Benefits for self and others from
injecting safely (−)

PS associated with:
-Benefits for self and others from
injecting safely (−)
-Self-efficacy to convince others to
inject safely (−)
Bailey et al. 2007 N=2420 young
IDUs in 5 U.S.
cities (n=568 at
follow-up)
(69% male;
median age 24
years)
IMB
SLT
Peer norms
Perceived risk of HIV/HCV
SS SS at baseline associated with:
-Perception that peers are neutral or
not against SS (+)
-Perceived risk of HIV from SS (−)

SS at follow-up associated with:
-Perception that peers were not against
SS (+)
-Perceived risk of HCV from SS (−)
Racz et al. 2007 N=150 IDUs in
Budapest,
Hungary
(75% male;
mean age 23
years)
HBM
TRA/TPB
Perceived susceptibility
Perceived severity
Perceived benefits
Perceived barriers to obtain sterile
needles
Self-efficacy
Perceived peer norms
Motivation to comply with peer
norms
SS, PS SS associated with:
-Perceived susceptibility (+)
-self-efficacy for sterile equipment use
(−)
-Motivation to comply with peer
norms for SS (+).
Stein et al. 2007 N=59 HCV-
negative IDUs
in Rhode
Island, U.S.A
(75% male;
mean age 34
years)
HBM HCV knowledge (including
severity)
Social network benefit
Perceived personal risk
(susceptibility)
Emotional pressure to share
(barrier)
Perceived access to clean needles
(barrier)
SS, PS In multivariate analysis, no individual
predictors associated with risk
behavior.
Thiede et al. 2007 N=1438 young
IDUs in 5 U.S.
cities
(55% male;
median age 15-
19 years)
SLT
IMB
Knowledge of HIV/HCV
transmission
Self-efficacy for avoiding PS
Peer norms for PS
PS
Syringe-mediated
drug splitting
PS associated with:
-Having friends who shared (+)
-Low self-efficacy for avoiding
sharing (+)
-Knowledge of HIV/HCV
transmission (−)
Parviz et al. 2006 N=242 IDUs in
Karachi,
Pakistan
(100% male)
none stated HIV knowledge SS SS associated with:
-HIV transmission knowledge (−)
Smyth &
Roche
2007 N=246 in-
treatment,
HCV-negative
IDUs in
Dublin, Ireland
(60% male;
median age 22
years)
none stated Perceived risk of SS with
acquaintances
Social distance
SS
Preparedness to
share in the future
SS associated with:
-Perceived risk of SS (−)
-Less social distance from partner

Preparedness to share in the future
associated with:
-Perceived risk in borrowing from sex
partners and close friends (−)
Kang et al. § 2004 N=952 IDUs
and crack
smokers in
New York
City, New
York, U.S.A.
(n=617; 70%
male; mean age
39 years) and
Bayamon,
Puerto Rico
(n=335; 78%
male; mean age
34 years).
SCT Self-efficacy for risk behavior
(change over time)
Receptive SS
Distributive SS
PS
SS at follow up associated with:
-Negative change in self-efficacy (+,
vs. no or positive change in self-
efficacy).
Longshore,
Stein, and
Conner§
2004 N=294 in-
treatment HIV-
IDUs (70%
male; mean age
45 yrs)
AARM AIDS Knowledge
Perceived susceptibility to AIDS
(due to past behavior)
Fear of AIDS
Peer norms for risk reduction
Perceived risk of infection (from
specific behaviors)
Response efficacy
Self-efficacy
Intended risk reduction
Injection Risk
Behavior (syringe-
mediated drug
splitting, PS, SS)
Risk behavior associated with risk
reduction intention (−)

Indirect effects on risk behavior:
-Susceptibility (+)
-Knowledge (−)
-Fear of AIDS (−)
-Peer norms (−)
-Self-efficacy (−)
Tortu et al. 2003 N=185 IDUs in
New York
City, New
York, U.S.A.
(0% male;
median age 39
years)
TRA* Perceived Barriers
Perceived Control
SS, PS
Syringe-mediated
drug splitting
Unsafe injection associated with:
-Lack of control over injection (+,
p=0.06)

Association between perceived
barriers and unsafe injection not
assessed.
Celentano et al.
§
2002 N=792 IDUs in
Baltimore,
Maryland,
U.S.A.
(79% male;
median age 38
years)
ARRM Self-efficacy for cessation and
safer injection
HIV knowledge
Frequency of
injection
SS, PS
Shooting gallery
use
Disinfection of
injection
equipment
Self-efficacy for cessation associated
with follow-up outcomes:
-Any drug injection (−)
-Daily injection (−, p=0.06)
-SS (−, p=0.05)
Smyth, Barry
& Keenan
2001 N=246 in-
treatment IDUs
in Dublin,
Ireland
(60% male;
median age 22
years)
none stated Perceived risk of SS with
acquaintances.
HCV knowledge.
SS SS associated with:
-Perceived risk in borrowing from
acquaintances (−, extremely dangerous
vs. not).
Avants et al. 2000 N=50 in-
treatment,
HIV+ IDUs in
Connecticut,
U.S.A.
(74% male;
mean age 42
years)
IMB Risk reduction intention
HIV risk knowledge
Motivation:
-Response efficacy
-Social norms
-Perceived likelihood of
transmitting or becoming
reinfected
-Pleasurability of condoms
Behavioral skills:
-Observation of skills
-Difficulty level of risk-reduction
behavior

Self-efficacy
Stage of Change
SS, PS In bivariate analysis, drug risk
behavior since learning of HIV+ status
associated with:
-Response efficacy (−)
-Social norms (−)
-Self-efficacy for negotiating safe
injection (−).

In multivariate analysis:
Drug risk in past 30 days associated
with:
-Behavioral skills (−)
-Motivation (−)
Hawkins et al. 1999 N=642 IDUs in
Baltimore,
Maryland,
U.S.A.
(83% male;
median age 40
years)
SCT
Social Network
Theory
Peer norms (verbal persuasion)
Perceived peer behavior
(modeling; observed behavior)
SS
Syringe cleaning
SS associated with:
-Peer encouragement to clean needles
(+, males)
-Perceived peer behavior (−, males and
females)

Syringe cleaning associated with:
-Perceived peer behavior (+, males
and females)
Brown 1998 N=140 in-
treatment or
SEP-attending
IDUs in New
York City,
New York,
U.S.A.
(0% male;
mean age 35
years)
HBM
SCT
AIDS risk perception
Perceived seriousness of HIV
Drug use self-efficacy
Social support
SS
Risky injection
location
SS and injecting in risky location
associated with:
-Self-efficacy for safer drug use (−)
Peters, Davies,
& Richardson
1998 N=480 in- and
out-of-
treatment IDUs
in Edinburgh,
Scotland
(72% male;
median age 27
years)
none stated HIV knowledge Receptive SS
Distributive SS
Inadequate
disinfection
SS not associated with HIV
knowledge.
Saelim et al. 1998 N=298 in-
treatment IDUs
in southern
Thailand
(100% male)
none stated Attitude towards risk of HIV
infection
HIV knowledge
SS SS associated with:
-HIV knowledge (−)
-Carefree attitude towards HIV risk (−)
Longshore,
Stein, and
Anglin§
1997 N=136 in-
treatment, HIV-
IDUs in Los
Angeles,
California,
U.S.A.
(47% male;
mean age = 38
years)
ARRM Perceived infection risk
Aversive emotion about AIDS
External cues to action
Peer norms for risk reduction
AIDS knowledge
Response efficacy
Self-efficacy for risk reduction
Behavioral intention (needle
cleaning)
Syringe
disinfection
Syringe disinfection at follow-up
associated with:
-Self-efficacy (+)

Self-efficacy associated with:
-Perceived infection risk (−)
-Peer norms for risk reduction (+)
-Knowledge (+)
Jamner, Corby
& Wolitski
1996 N=443 IDUs in
Long Beach,
California,
U.S.A. (62%
male; modal
age 31-40
years)
TRA/TPB *
IMB*
Attitudes towards bleaching
Social Norms
Perceived behavioral control
Perceived susceptibility
Response efficacy
Perceived risk of unsafe sharing
Exposure to AIDS prevention
information
Intentions to
bleach
Frequency of
bleaching
Intentions and frequency of bleaching
associated with:
-Attitudes (+)
-Social norms (+)
-Perceived behavioral control (+)
-Perceived risk of unsafe sharing (+).

Intention (but not frequency)
associated with:
-Exposure to AIDS-prevention
information (+)
Falck et al. 1995 N=118 IDUs in
Columbus and
Dayton, Ohio,
U.S.A.
(76% male;
median age 31-
40 years)
HBM Perceived Susceptibility
Seriousness
Benefits
Barriers
Self-efficacy
Frequency of drug
injection and
syringe use
behaviors
Safer injection associated with:
-Self-efficacy (+)
-Susceptibility (−)
Robles et al. § 1995 N=1740 IDUs
in Puerto Rico
(80% male;
median age 25-
34 years)
none stated Perceived risk of AIDS SS, PS
Injection in
shooting galleries
Syringe
disinfection
High perceived risk of getting HIV
prospectively associated with:
-Sharing syringes (+)
-Sharing cookers (+)
-Using shooting galleries (+)
Sarkar et al. 1995 N=488 in-
treatment or
incarcerated
IDUs in
Manipur, India
(99% male;
median age 26
years)
none stated HIV knowledge SS SS not associated with knowledge of
HIV transmission or serostatus
Booth 1994 N=378 IDUs in
Denver,
Colorado,
U.S.A.
(69% male;
mean age 38
years)
HBM* Perceived chance of getting AIDS
(susceptibility)
Exposure to AIDS interventions
SS SS associated with:
-Perceived chance of getting AIDS (+)
-Exposure to AIDS interventions (−)
White et al. 1994 N=193 in-
treatment IDUs
in Australia
none stated HIV knowledge Risky injection Risky injection associated with:
-HIV knowledge (−)
Gibson et al. 1993 N=226 in- and
out-of-
treatment IDUs
(67% male;
median age 30-
39 years)
HBM AIDS knowledge
AIDS anxiety
Perceived susceptibility
Self-efficacy
Response efficacy
Communication skill in
negotiating safe syringe practices
SS SS associated with:
-Self-efficacy (−)
Hartgers et al.
§
1992 N=92 HIV-
IDUs in
Amsterdam,
Netherlands
(60% male;
mean age 33
years)
PMT Perceived severity of HIV
Perceived vulnerability to HIV
Response efficacy
Self-efficacy
Behavioral intention to inject
safely
Injection risk:
Borrowed syringe
but did not
disinfect
Borrowed and
disinfected
Did not borrow
Safe injection associated with:
-Participation in SEP (+)
-Perceived vulnerability (−)
*

Theoretical foundation not stated, but implied by selection of constructs

§

Note: Demographic summaries provided where available. Study design is cross-sectional unless noted. HIV serostatus of sample is mixed, unless noted in sample description. SS = Receptive Syringe Sharing. PS = Paraphernalia Sharing.

Table 2.

Intervention studies using cognitive behavioral theories or theoretical constructs to change injection risk behavior.

Study Year Sample Study Design Theoretical
Foundation
Relevant
Theoretical
Constructs
Main Drug-
related
Outcome
Significant Findings Related to
Theoretical Constructs of Interest and
Drug-related Outcomes
Latka et al. 2008 N=418 HIV−
and HCV+
IDUs in 3
U.S. cities
(77% male,
mean age 27
years)
RCT, with
assignment to 6-
session peer
mentoring or
attention control
conditions.
SCT Behavioral skills
HCV knowledge
Engaging in peer
mentoring
Self-efficacy
Injection risk
behavior
(distributive
SS, syringe re-
use, PS,
injection drug
use)
At 3-month follow-up, experimental
condition associated with reduction in:
-Distributive SS (p=0.07)
-Syringe re-use
-PS
-Cessation of injection

Only PS sustained at 6-month follow-
up.

Intervention associated with increased
self-efficacy, which was associated
with less distributive risk behavior at 3-
month follow-up.
Copenhaver &
Lee

Copenhaver et
al.
2006

2007
N=226 in-
treatment
IDUs in
New Haven,
Connecticut,
U.S.A.
(51% male;
mean age 39
years)
Non-
experimental,
intervention pre-
post
with no
control group.
IMB HIV-risk
reduction
knowledge
Motivation:
-Behavioral
intentions
Perceived social
norms
Self-efficacy
Frequency of
IDU
SS, PS
Syringe
cleaning
Significant intervention effects on
drug-related risk reduction outcomes,
driven by improvements in knowledge.

In SEM analysis, drug-risk reduction
associated with self-efficacy (+)

Personal motivation associated with
self-efficacy (+)

Social motivation (social norms) to
reduce drug risk (+) and information
(knowledge) (+) associated with
personal motivation.
Avants et al. 2004 N=220 in-
treatment
IDUs
(~67% male;
mean age
~37 years)
RCT with
assignment to
standard care or
12-session Harm
Reduction Group
(HRG)
IMB HIV
transmission
Knowledge
Motivation:
-Intentions to
reduce risk
-Social norms for
using bleach
-Perceived
difficulty of
bleaching
-Response
efficacy
-Perceived
vulnerability
Behavioral
skills:
-Observed skills
-Self-efficacy
Drug use
SS, PS
Re-use of
syringes
Intervention associated with:
-Abstinence from cocaine
-Drug-related HIV risk reduction
knowledge
-Improvement in syringe cleaning skills

No intervention effects for SS or self-
efficacy.

Perceived difficulty of using sterile
needles decreased in both groups, and
vulnerability to HIV increased in both
groups. Intention to use sterile syringes
increased in both groups.

No change in importance of using
sterile needles in social network (social
norms), or response efficacy of using
sterile needles.
Robles et al. 2004 N=557 out-
of-treatment
IDUs in
Vega Baja,
Puerto Rico
(89% male;
modal age
25-34 years)
RCT with
assignment to 2-
session HIV
counseling/testing
only, or HIV
counseling/testing
plus 6-session
Motivational
Interviewing and
case management
intervention.
none stated Self-efficacy to
change
Self-efficacy to
avoid needle or
sexual risk
behavior
SS, PS,
Discontinuatio
n of drug use
Drug treatment
entry
Pooling money
to buy drugs
Experimental condition associated
with:
-Greater entry into drug treatment
-Greater discontinuation of drug
injection
-Reduction in SS among those who
continued to inject
-Increased self-efficacy to refuse to
share needles

Self-efficacy to refuse to share needles
associated with non-significant
reduction in SS (p>0.05)
Margolin et
al.
2003 N=90 HIV+,
in-treatment
IDUs in
New Haven,
Connectcut,
U.S.A.
(70% male;
mean age 41
years)
RCT with
assignment to
Enhanced
Methadone
Maintenance
Program (E-
MMP) or
HIV+Harm
Reduction
Program
(HHRP+).
IMB HIV/AIDS
transmission
knowledge
Motivation:
-Self-efficacy
-Behavioral
intention
-Social norms
-Perceived
difficulty
Behavioral skills
(observed)
SS, PS
Frequency of
drug use
Adherence to
antiretroviral
medication
Experimental condition (HHRP+)
associated with:
-Greater reductions in rates of overall
sex and drug risk behaviors
-Greater improvements in sex and drug-
related behavioral skills
-Lower rates of non-adherence to
antiretroviral therapy
-Greater reduction in addiction severity
-Greater reduction in opiate use

Marginal intervention effect on drug-
related knowledge, no effect on
motivation.
Booth,
Kwiatkowski
& Stephens
1998 N=3743
IDUs from
eight U.S.
cities
(71% male;
mean age 39
years)
RCTs with
assignment to
NIDA/CA
standard
intervention, or
the standard
intervention plus
site-specific
enhanced
intervention.
HBM
Communication
Theory
Efficacy
Theory
Perceived risk of
getting AIDS
HIV serostatus
Exposure to prior
HIV
interventions
Cessation of
injection
Frequency of
injection
SS, PS
Entry into drug
treatment
Significant reductions in:
-frequency of injection
-SS
-PS

Intervention associated with:
-Cessation of injection
-Entry into drug treatment

Perceived risk of getting AIDS
associated with maintaining or
increasing high-risk behaviors.
Sorensen et al. 1994 Study 1:
N=50 in-
treatment
IDUs in San
Francisco,
California,
U.S.A. (66%
male; mean
age 41
years)
Study 2:
N=98 in-
treatment
IDUs in San
Francisco,
California,
U.S.A. (65%
male; mean
age 37
years)
RCT with
assignment to 6-
session small
group
Psychoeducational
intervention or
information
condition.
Health
psychology
AIDS
knowledge:
-Factual
knowledge
-Knowledge of
AIDS risk
reduction
Susceptibility to
AIDS
Anxiety about
AIDS
Response
efficacy
Self-efficacy
Communication
skills
Demonstrable
skills
SS
Frequency of
drug use
Use of
sterilized
needles
Study 1:
At post-test, intervention associated
with:
-Factual knowledge about AIDS
-Drug-related self-efficacy
At 3-month follow-up, intervention
associated with:
-Factual knowledge about AIDS
-AIDS anxiety
Both groups maintained low rates of
drug use and SS

Study 2:
At post-test, intervention associated
with:
-Factual knowledge of AIDS
-Self-efficacy (comparison >
experimental)
At 3-month follow-up, intervention
associated with:
-Perceived susceptibility to AIDS
-No effect on SS. However, two
outliers strongly influenced results.

Note: Demographic summaries provided where available; HIV status of sample is mixed unless noted in demographic summary. SS = Receptive Syringe Sharing. PS = Paraphernalia Sharing. RCT = Randomized Controlled Trial. Only constructs and outcomes relevant to injection-related risk are shown.

The intervention studies ranged in scale from large, multi-site studies to small, single-site studies. All were conducted in the U.S. or Puerto Rico, though one report did not specify the exact location. Of the seven intervention studies, four targeted in-treatment IDUs, including individuals in MMP or outpatient detoxification programs. One study enrolled only HIV-positive individuals, and one enrolled only HCV-positive individuals. Six of the seven studies randomly assigned participants to either an enhanced intervention condition or a control, consisting of either an attention control or a standard of care. One study was not experimental in nature, and instead employed a single-group, pretest/posttest design. Among the intervention studies, most had follow-up periods ranging from three to 12-months post intervention.

Theories examined

CBTs employed by the 33 studies included IMB, HBM, SLT/SCT, Efficacy Theory, TRA/TPB, PMT, and ARRM. No studies were identified that used Fishbein’s Integrated Model. Not all the constructs in the theoretical models were examined by the reviewed studies; constructs that were examined included: self-efficacy, response efficacy, perceived susceptibility, perceived severity, social norms, HIV transmission knowledge, behavioral skills, behavioral intentions, perceived rewards/benefits of risk reduction, and perceived barriers to risk reduction. No studies were found that examined outcome expectancies, outcome expectations, attitudes, or emotional coping responses.

Associations between theoretical constructs and injection risk behavior

Self-efficacy

High self-efficacy for risk reduction (i.e., one’s perception of his/her ability to successfully execute a proposed health behavior) was consistently inversely associated with injection risk (Avants et al., 2000; Brown, 1998; Celentano et al., 2002; Falck et al., 1995; Gibson et al., 1993; Longshore et al., 1997; Longshore et al., 2004; Racz et al., 2007; Thiede et al., 2007). A decrease in self-efficacy was found to predict increased syringe sharing at follow-up (Kang et al., 2004). Low self-efficacy for convincing others to inject safely was also positively associated with increased paraphernalia sharing (Cox et al., 2008).

Results of interventions targeting self-efficacy as a means of reducing injection risk behavior have been mixed. A multi-site, secondary prevention intervention trial among young HCV-positive, HIV-negative IDUs demonstrated significant intervention effects on distributive injection risk behaviors. In mediation analyses the experimental condition was significantly associated with increased self-efficacy, which was in turn associated with reduced distributive injection risk behaviors (Latka et al., 2008). An IMB-based, non-experimental intervention among in-treatment IDUs found that self-efficacy to reduce drug-related risk behavior mediated the association between more distal factors (i.e., motivation, social norms, knowledge) and drug risk reduction outcomes (Copenhaver & Lee, 2006). A combined Motivational Interviewing and case management intervention among IDUs in Puerto Rico found a significant intervention effect on self-efficacy to reduce syringe sharing, but not on self-efficacy to stop pooling money to buy drugs or to stop sharing cotton (Robles et al., 2004). Self-efficacy was associated with a reduction in syringe sharing that did not achieve statistical significance. Two small intervention studies among clients in MMP and outpatient drug treatment investigated intervention effects on self-efficacy for avoiding HIV via drug use (Sorensen et al., 1994). Both found effects on self-efficacy to reduce drug-related risk behavior at post-test, but the effects were not sustained at 3-month follow-up. In the second study, however, the intervention effect was in an unexpected direction – a significant increase in self-efficacy was found in the control condition but not the experimental condition. Overall, the intervention showed few effects on risky injection practices. In an IMB-based intervention, participants in both the control and intervention arms reported relatively high levels of drug-related self-efficacy, but there was no effect of time or condition (Avants et al., 2004).

In sum, 16 studies examined at least one type of self-efficacy. In our review, eleven epidemiological studies noted that self-efficacy to reduce injection risk was inversely associated with injection risk. Findings from interventions designed to change self-efficacy resulted in effects in some domains of self-efficacy, though conclusions regarding the role of improved self-efficacy in mediating intervention effects were somewhat less robust.

Response Efficacy

Response efficacy (i.e., an individual’s belief that engaging in a protective behavior will successfully avert the health threat) was examined in six studies. One small cross-sectional study among in-treatment, HIV-positive IDUs found that individuals who engaged in syringe sharing were less confident that not sharing injection equipment reduces HIV risk (Avants et al., 2000), but others have found no association with injection risk behavior (Gibson et al., 1993; Hartgers et al., 1992; Jamner et al., 1996; Longshore et al., 1997; Longshore et al., 2004). No changes in confidence that using new/cleaned needles reduces HIV transmission were detected in an IMB-based intervention study among in-treatment IDUs (Avants et al., 2004). Response efficacy does not appear to be strongly associated with injection risk behaviors.

Perceived Susceptibility

The preponderance of findings suggests that perceptions of high susceptibility to HIV are associated with increased injection risk behavior (Booth, 1994; Falck et al., 1995; Hartgers et al., 1992; Longshore et al., 2004; Racz et al., 2007; Robles et al., 1995). This positive association has been found in both cross-sectional and longitudinal studies. In a structural equation modeling analysis, perceived susceptibility had a positive indirect association with injection risk behavior (Longshore et al., 2004). Though less common, others have found a negative association between perceived susceptibility or perceived risk of HIV and injection risk behavior (Bailey et al., 2007; Smyth et al., 2001; Smyth & Roche, 2007). In still other multivariate analyses, no association was detected between perceived vulnerability (Avants et al., 2000), perceived susceptibility (Gibson et al., 1993), or perceived risk of HIV/AIDS (Brown, 1998; Longshore et al., 1997; Stein et al., 2007) and injection risk behavior. In a study that assessed both personal susceptibility and perceived risk of unsafe sharing, frequency of bleaching injection equipment was associated with the perceived risk of unsafe sharing, but not susceptibility (Jamner et al., 1996). Intervention studies designed to manipulate perceptions of susceptibility or vulnerability have had some success, with few ultimate effects on injection risk behavior (Avants et al., 2004; Sorensen et al., 1994). An evaluation of eight National Institute on Drug Abuse Cooperative Agreement intervention sites found that individuals who perceived a greater than 50% chance of contracting AIDS were more than twice as likely to share syringes at follow-up (Booth et al., 1998). In sum, findings regarding perceptions of susceptibility to HIV/AIDS via drug injection have been mixed. Most studies found a positive association between high perceived susceptibility and injection risk behavior, while fewer found the theoretically-predicted negative association. Others found no association. Importantly, many studies reviewed here used different operational definitions of the construct, which may contribute to the varying results.

Perceived Severity

Perceived severity, or the individual’s opinion of the seriousness of the illness in question and its consequences, is an important cognitive variable in several theoretical models, but has been examined by relatively few studies. Most studies have not identified strong associations between the construct and behavior (Brown, 1998; Hartgers et al., 1992; Racz et al., 2007) and no intervention studies reported attempting to manipulate perceived severity. Longshore and colleagues (2004) did find that fear of AIDS, measured with a single item “Getting AIDS is just about the worst thing that could happen to me” had a significant indirect effect on injection risk behavior in one study, while a similarly worded question had no effect on syringe disinfection in another (Longshore et al., 1997).

Perceived Social or Subjective Norms

Perceived social or subjective norms represent the individual’s perception of his/her associates’ approval or disapproval of a behavior (i.e., normative beliefs), usually weighted by the individual’s motivation to comply with those normative beliefs. Social or subjective norms supporting safer injection practices have been found most frequently to be inversely associated with risky injection (Avants et al., 2000; Bailey et al., 2007; Jamner et al., 1996; Longshore et al., 1997; Longshore et al., 2004). In a sample of young IDUs from five U.S. cities, participants who reported that their peers were neutral or did not oppose syringe sharing were nearly three times as likely to report recent receptive syringe sharing than those whose friends were against syringe sharing (Bailey et al., 2007), and were four times as likely to share paraphernalia than those whose friends did not share (Thiede et al., 2007). Peer norms for sterile equipment use were not associated with injection risk among IDUs in Budapest, Hungary, however those who reported motivation to comply with peer pressure to share injection equipment were seven times as likely to share injection equipment (Racz et al., 2007).

In a large sample of not-in-treatment IDUs, observation of safer behavior among peers (e.g., “Do your shooting buddies always clean their used needles with bleach before shooting with a used needle?”) was associated with both less needle sharing and more needle cleaning in a sample of IDUs from Baltimore, Maryland (Hawkins et al., 1999). However, encouragement from peers to engage in safer behavior (e.g., “How many shooting buddies have encouraged you to clean your needles with bleach?”) was associated with increased reports of sharing unsterilized needles. The authors offer possible explanations for this finding, but due to the cross-sectional nature of the study design, these explanations could not be tested. Perceived peer behavior, measured by asking participants whether their shooting buddies clean their injection equipment, could represent SCT’s “observational learning” construct. It could also represent a variety of perceived norm described as a “descriptive norm” (Davey-Rothwell & Latkin, 2007). Though social norms regarding injection practices appear to be important predictors of behavior, attempts to manipulate them alone (Avants et al., 2004) or as part of a higher-order motivation factor (Margolin et al., 2003) have had limited success. The effect of social motivation to reduce drug risk was indirectly associated with risk reduction behavior in one non-experimental trial (Copenhaver et al., 2006).

Knowledge

Knowledge about the risk of HIV or HCV infection via drug injection was found to have a negative association with risk behavior in two studies based in Thailand and Australia (Saelim et al., 1998; White et al., 1994). Young IDUs in five U.S. cities who believed that HIV/HCV transmission via paraphernalia sharing was unlikely were more likely to share paraphernalia than those who believed such transmission was likely (Thiede et al., 2007). No association with injection risk behavior was found in eight other studies based both in the U.S. and abroad (Avants et al., 2000; Celentano et al., 2002; Cox et al., 2008; Gibson et al., 1993; Peters et al., 1998; Sarkar et al., 1995; Smyth et al., 2001; Stein et al., 2007). Some propose that knowledge is a necessary, but not sufficient condition for behavior change and that its effect is mediated by other constructs (Catania et al., 1990; Fisher & Fisher, 1992). In support of this view, three studies based in the U.S. have found indirect associations between knowledge and behavior, mediated by variables such as self-efficacy, personal motivation, and behavioral intentions (Copenhaver & Lee, 2006; Longshore et al., 1997; Longshore et al., 2004). Others have found exposure to AIDS-prevention information to be associated with intentions to clean syringes, but not with the frequency of actually cleaning syringes (Jamner et al., 1996).

In a non-experimental intervention trial among MMP patients, an IMB-based intervention showed significant intervention effects on overall drug-related outcomes, driven primarily by an improvement in knowledge scores (Copenhaver et al., 2007). Two other IMB-based intervention studies have succeeded in changing HIV knowledge, however neither demonstrated a strong intervention effect on injection risk behavior (Avants et al., 2004; Sorensen et al., 1994). Another IMB-based intervention found a marginally-significant Time × Treatment interaction for effects on HIV transmission knowledge (Margolin et al., 2003). In sum, HIV knowledge appears to be associated with risky behavior in some studies, and analyses that account for indirect or mediated effects may be more likely to detect such an association. Increasing knowledge may be an important component of interventions but may be insufficient to change behavior in the absence of other factors.

Behavioral Skills

The concept of behavioral skills is usually assessed as a combination of actual skills (e.g., communication or assertiveness) and self-efficacy, or one’s belief in one’s ability to use those skills. Communication skills to negotiate safer behavior and demonstrable risk reduction skills were examined in two observational studies, which found associations between increased behavioral skills and reduced injection risk behavior (Avants et al., 2000; Gibson et al., 1993). Three interventions attempted to manipulate behavioral skills. In the first, in-treatment IDUs assigned to the experimental condition succeeded in increasing needle-cleaning skills compared to a control condition, however there was no intervention effect on injection risk behavior (Avants et al., 2004). In the second, also among in-treatment IDUs, participants in the experimental condition were less likely than controls to report needle sharing and significantly improved both syringe cleaning and condom use skills relative to those assigned to control (Margolin et al., 2003). In the third, syringe disinfection skills improved for both conditions at post-test, but there was no statistically significant intervention effect (Sorensen et al., 1994). In sum, while only examined in a few studies, it appears that interventions may succeed in improving behavioral skills. However, more evidence may be required to support an association between improved behavioral skills and ultimate reductions in risk behavior.

Behavioral Intentions

Behavioral intentions are theorized to be the most proximal predictor of health behavior. Intentions, in turn, are predicted by one’s attitudes towards the behavior and subjective norms regarding the behavior.

Behavioral intentions have received mixed support in the literature attempting to explain injection risk behavior. Some investigators have found no effect of intentions on subsequent injection risk behavior (Hartgers et al., 1992; Longshore et al., 1997). Others have found support for a strong negative effect of intentions to reduce risk on subsequent risk behavior (Longshore et al., 2004) and support for the effect of increased motivation (comprised of behavioral intentions and perceived social norms) on self-efficacy for risk reduction (Copenhaver & Lee, 2006). The role of perceived behavioral control as a potential moderator of the effects of intentions on behavior is one possible explanation for inconsistent findings regarding this construct – intentions may only influence behavior if the individual has the ability to perform the behavior (Ajzen, 1991).

Perceived Barriers, Benefits, and Behavioral Control

Perceived barriers to safer behavior represent perceptions of those social or environmental factors that inhibit or constrain the practice of a safer behavior. Perceived benefits, on the other hand, represent an individual’s opinion of the efficacy of the recommended health behavior to reduce the threat of disease (Strecher & Rosenstock, 1997). This construct is similar to response efficacy (described above), in which an individual assesses the likelihood that the recommended action will succeed in averting the threat. It is also similar to the construct of outcome expectancies that is described in the SCT as the value placed on a particular outcome (Bandura, 1986; Baranowski et al., 1997). Perceived behavioral control describes the ability that an individual feels he/she has to perform the behavior in question and to overcome impediments or barriers to its performance (Ajzen, 1991).

The most commonly investigated costs of or barriers to safer injection are difficulty accessing sterile injection supplies and social sanctions for engaging in safer behavior. In a sample of IDUs from Montreal, Canada, difficulty injecting safely due to lack of equipment was associated with syringe sharing (Cox et al., 2008). In the same study another measure of barriers, the detrimental effect of not sharing on personal relationships, was not associated with the behavior in multivariate analysis. In a study employing the HBM, associations were found between inconvenience in accessing sterile syringes and violation of social norms due to a refusal to share and other HBM constructs such as self-efficacy or perceived susceptibility, but not with injection risk behavior (Falck et al., 1995). Others have found no associations between perceived barriers and injection risk behavior in multivariate analysis (Racz et al., 2007; Stein et al., 2007).

In the same Montreal sample, perceived benefits of injecting with sterile equipment were associated with reduced syringe and paraphernalia sharing (Cox et al., 2008). Like perceived barriers, perceived benefits were also associated with other constructs in an HBM-based study, including self-efficacy and perceived seriousness of HIV/AIDS, but not injection risk behavior (Falck et al., 1995). Still others have found no association between perceived benefits and injection risk behavior (Racz et al., 2007; Stein et al., 2007). In one study with exclusively female participants, not feeling in control over the injection episode (perceived behavioral control) was marginally associated with injection risk behavior (Tortu et al., 2003).

In sum, four studies measured perceived barriers and/or benefits. Findings were largely mixed, though in the expected direction when associations were detected. One study examined perceived behavioral control and found a marginal association with injection risk behavior.

V. Discussion

In summary, CBTs contain several constructs that are theorized to predict health behavior. In the context of injection risk behavior, some have received more empirical support than others. We found strong and fairly consistent support for the role of some cognitive constructs in explaining injection risk behavior (e.g., self-efficacy, social norms). For others, we found mixed results (e.g., perceived susceptibility, knowledge, behavioral skills, behavioral intentions, perceived barriers, perceived benefits), while still others have received comparatively less attention (e.g., response efficacy, perceived severity, perceived behavioral control). Overall, findings from intervention studies designed to change these theorized predictors of behavior, when available, were mixed, though some CBT-based interventions did yield significant reductions in injection risk behavior.

Several explanations may be put forth for the mixed findings regarding some constructs. First, there have been inconsistencies in the operationalization of the theories, including theoretical constructs, dependent variables, and the comprehensiveness with which theories are employed. Second, a growing literature emphasizes the need to contextualize findings from CBT studies within the larger “risk environment” in which injection risk behavior is “produced and reproduced” (Rhodes, 2002). No studies we reviewed explicitly controlled for environmental conditions. Under conditions where environmental influences are, relatively speaking, stronger than cognitive behavioral constructs, modest effects of CBT constructs would be expected.

Inconsistencies in the operationalization of theories and theoretical constructs

To some extent, the inconsistencies in findings from the studies reviewed here may have to do with the different ways in which variables are operationalized, assumptions made in the statistical modeling process, or the differing extent to which theoretical models are employed. Several CBTs employ constructs with a large degree of overlap (Bandura, 2004; Wallston & Wallston, 1984). For example, the IMB’s concept of “motivation” is comprised of response efficacy, social norms, perceived susceptibility, and perceived rewards. Therefore, it is somewhat difficult to tease out the relative effects of these individual constructs.

Perceived susceptibility, in particular, has yielded inconsistent results. In some studies there appears to be a positive association between high perceived susceptibility to HIV and increased risk behavior (Booth, 1994; Booth et al., 1998; Falck et al., 1995; Hartgers et al., 1992; Longshore et al., 2004; Racz et al., 2007; Robles et al., 1995). In cross-sectional studies, this positive association may demonstrate an accurate assessment of risk (Kowalewski et al., 1997). The HBM theorizes that higher perceptions of susceptibility should predict less risk behavior in the future. However, fewer studies reviewed here found the association in the expected direction (Bailey et al., 2007; Smyth et al., 2001; Smyth & Roche, 2007), and few longitudinal studies have examined the role of perceived susceptibility in changing subsequent behavior. As has been discussed by others (Kowalewski et al., 1997; Strecher & Rosenstock, 1997), the underlying concept of perceived susceptibility has been measured differently, possibly leading to variations in results. Longshore and colleagues (2004) measured both perceived susceptibility and perceived risk of infection. Perceived susceptibility to AIDS was defined as a general susceptibility, while perceived risk of infection was defined as the risk associated with specific behaviors. In their analysis, perceived susceptibility was associated with weaker risk reduction intentions and greater risk behavior at follow-up, while perceived risk of infection associated with specific behaviors was not associated with risk behavior at baseline or follow-up. Other studies in this review measured perceived risk in terms of a general susceptibility to AIDS (e.g., “How likely are you to develop AIDS?”), while still others operationalized perceived susceptibility as a mix of general and specific questions (e.g., “I am at risk of HIV” and “Due to my injecting drug use I may get HIV”). While clearly an important theoretical correlate of behavior, more work is needed to determine which conceptualization of the construct is most useful.

In addition, differences in the measurement of the dependent variable, injection risk behavior, may contribute to divergent findings. HIV-related injection risk behaviors have been measured multiple ways in the literature, including the use of study-specific items measuring the frequency of individual behaviors on Likert-type response scales (e.g., Longshore et al., 2004), individual items measuring behavior as a series of dichotomous items (e.g., Robles et al., 1995), and scales such as the Risk Behavior Assessment or Risk Assessment Battery, either used in their entirety (e.g., Falck et al., 1995), or as a smaller subset of items (e.g., Stein et al., 2007) The convention of measuring injection risk behavior as a dichotomous “any” versus “no” risk in a specified time period may be particularly difficult, since the injection of some types of drugs (e.g., opioids) occurs many times per day, every day. Given the frequency with which injection drug use occurs, the most proximal predictors of injection risk behavior may vary for each injection episode. Additionally, the statistical distribution of these variables often makes the use of analytic methods assuming normally-distributed variables problematic.

Though seldom investigated, it is also possible that non-linear associations exist between independent and dependent variables. Thresholds after which the independent variable no longer influences injection risk behavior may be an important consideration for future studies dedicated to fine-tuning our understanding of the influence of cognitive constructs. Though few theories provide guidance for modeling non-linear effects, there are some that provide hypotheses about effect modification (i.e., interactions between constructs) that are also rarely modeled. For example, the PMT hypothesizes an interaction, or “boomerang effect”, between perceived vulnerability and response efficacy (Rogers, 1983).

It is also possible that interactions with other variables such as drug treatment involvement, HIV status, or the perceived (or known) HIV status of injection partners may influence the main effects of cognitive constructs. Of particular interest is the influence of known (or suspected) HIV status on HIV cognitions and risk behavior. While one’s HIV status may influence many of the HIV cognitions discussed here, we will focus specifically on perceived susceptibility for illustrative purposes. It is presumed that someone who knows he/she is infected with HIV will perceive less susceptibility to HIV infection via syringe sharing than someone who believes that he/she is HIV negative. In addition to having different baseline levels of susceptibility, it is also possible that perceptions of susceptibility influence injection risk behavior differently for HIV-positive and HIV-negative individuals, suggesting an interactive effect that has yet to be assessed. Some studies reviewed here restricted enrollment to HIV-negative individuals (Bailey et al., 2007; Hartgers et al., 1992; Longshore et al., 1997; Longshore et al., 2004); two found positive associations, one found a negative association, and one found no association between perceived susceptibility, risk or vulnerability and risk behavior. In the one study that restricted enrollment to HIV-positive IDUs, no association was found between perceived likelihood of transmitting HIV or becoming reinfected and injection risk behavior (Avants et al., 2000). The majority of studies reviewed here enrolled samples with mixed serostatus, and most explicitly controlled for HIV status in multivariate analyses. Of these, five found positive associations, one found a negative association, and four found no association between susceptibility and risk behavior. One factor complicating conclusions is whether participants are aware of their own serostatus. Neither Tortu and colleagues (2003) nor Sarkar and colleagues (1995) found associations between awareness of HIV serostatus and injection risk behavior, though other larger studies have reported reduced transmission behavior among seroaware HIV-positive IDUs (Des Jarlais et al., 2004). Another complicating factor is the known or suspected HIV serostatus of the injection partner; a partner who is known to be HIV positive might be perceived as a greater risk than one whose status is unknown or known to be HIV negative. It appears that the confounding or effect modifying influence of HIV serostatus on the association between HIV cognitions and injection risk behavior remains unclear.

A less significant issue in this stage of the epidemic, but one still relevant for interpreting earlier studies, is confusion surrounding the terms HIV and AIDS. Particularly in the early years of the epidemic, but still true today, many laypeople use the terms interchangeably. Some early studies asked variations of the question, “How likely do you think you are to develop AIDS?” (e.g., Booth, 1994; Robles et al., 1995). This question has a different meaning for someone who believes he/she is HIV-negative, than for someone who believes he/she is HIV-positive. With the success of Highly Active Anti-Retroviral Therapy (HAART) in delaying the onset of AIDS for many years, the time between acquiring HIV infection and developing AIDS has increased dramatically. However, in early studies that assessed the risk of acquiring AIDS and/or HIV, the meaning of the construct may be slightly different. Similarly, studies have found discrepancies between self-reported HIV status and HIV test results among IDUs (Latkin & Vlahov, 1998; Strauss et al., 2001). Underreported HIV infection among HIV-positive IDUs may be due to failure to understand testing results, or failure to obtain previous testing results (Fisher et al., 2007).

While it is to be expected that the definition of concepts and the precision of analyses will improve as the scientific literature grows, it has been noted elsewhere that existing differences make comparison of the findings from some studies difficult (Kowalewski et al., 1997). Future psychometric studies employing factor analysis methods to more clearly differentiate between various measures of similar constructs, and more sophisticated analysis techniques that account for non-linear associations and effect modification will be required to more precisely model the constructs that are theoretically important in predicting injection risk behavior.

Finally, there is a tendency to selectively employ some, but not all, of the constructs included in CBT models. While many empirical studies cite their theoretical orientation, it is rare to find a study that both measures all the relevant constructs and assesses their associations according to the recommendations of the theory. As such, it is difficult to evaluate whether inconsistent findings are due to a failure of the theory or a failure of study design, and is also difficult to evaluate which theory has the best predictive potential.

Need to integrate social, structural, and environmental context of behavior

More than fifteen years ago, Hartgers et al. (1992) concluded that “social cognitive factors contribute little to the prediction of safe injecting, possibly because, through situational factors and drug use habits…IDUs have little control over their injecting risk behavior.” And, more recently, Rhodes and colleagues (2005) found that individual-level interventions that do not account for environmental influences account for approximately 25% to 40% reductions in injection risk behavior. Though we have observed dramatic decreases in both injection risk behavior and HIV prevalence in some areas since the advent of the HIV epidemic (Des Jarlais & Semaan, 2008), injection risk behavior persists, and the task of developing even more effective interventions remains. It has been proposed that the way forward lies in integrated interventions that account for both individual- and environmental-level factors (Metzger & Navaline, 2003).

Some theories may be more amenable than others to helping researchers integrate cognitive and environmental constructs. For example, SCT, which highlights the “reciprocal determinism” among environment, person, and behavior (Bandura, 1986), provides one framework for this type of understanding. Empirical studies of injection risk behavior employing SCT have generally measured self-efficacy and perceived social norms. Findings from this review suggest that both self-efficacy and perceived social norms are, in fact, strong and consistent correlates of injection risk behavior. The social environment is only one aspect of the broader environmental context in which risk behavior occurs. Others include the physical, economic, and political (Rhodes, 2002). Environmental factors such as legal jeopardy and threat of incarceration for carrying injection supplies (Burris et al., 2004; Friedman et al., 2006; Martinez et al., 2007), drug market conditions that create economic interdependence (Koester et al., 2005; Needle et al., 1998), poverty, and homelessness (Des Jarlais et al., 2007a) have all been shown to influence injection risk behavior, and could be measured in addition to the social environment.

The reinforcing properties of these environmental factors may serve to inhibit or perpetuate injection risk behavior. If they are not included in statistical models designed to determine the association between cognitive constructs and behavior, their influence may confound the association between cognitions and behavior, leading to inconsistencies or difficulties in interpretation. Further, the effects of environmental factors may moderate the association between cognitions and behavior, such that influence of cognitive constructs (e.g., perceived susceptibility) on behavior is only detectable in the presence or absence of certain environmental conditions (e.g. threat of incarceration for carrying syringes). The use of integrative models may hold promise as researchers seek to further elucidate those factors that perpetuate injection risk behaviors in the presence of existing interventions.

V. Conclusions

Evidence for the ability of cognitive constructs to explain the “residual injection risk behavior” (Des Jarlais et al., 2007b) that persists in the third decade of the HIV epidemic is still being accumulated and shows variable success, though there is strong evidence that some cognitions are associated with behavior. At the same time, structural interventions are being discussed as the next wave of intervention possibilities (Blankenship et al., 2006; Rhodes et al., 2005). Future studies will benefit from an explicit integration of individual- and environmental-level constructs, and an attention to the social and structural environmental factors that prohibit IDUs from engaging in risk reduction. The use of theoretical constructs such as perceived social norms and perceived barriers and benefits, which measure the perceived social and structural environment can be one step towards integrating cognitive behavioral and structural or environmental models.

Implications for Practice

This integration has direct implications for the design of interventions that target both cognitive constructs and the risk environment. Comprehensive HIV prevention programs that provide services such as permanent supportive housing, legal advocacy, case management, referrals to drug detoxification and treatment in addition to theoretically-based HIV prevention programming for IDUs can simultaneously address HIV-related cognitions, social norms, and environmental barriers to behavior change. For example, an intervention that provided HIV counseling and testing, case management, and motivational interviewing to enhance self-efficacy was effective in increasing entry into drug treatment, discontinuing drug injection, and reducing needle sharing (Robles et al., 2004). Amendments to existing paraphernalia laws or policing tactics that target drug users for harassment, arrest, and incarceration could also remove significant barriers to safer injection. A combination of developing pro-health cognitions via behavioral intervention while simultaneously reducing the environmental barriers to safer behavior and amending perceived social norms is hypothesized to lead to greater intervention effects than either strategy would alone.

VIII. Acknowledgements

This report has been supported by a National Cancer Institute training grant T32CA09492, NIDA grant DA010366, and NIDA grant R01DA014210. We extend our warm thanks to the two anonymous reviewers who provided insightful commentary and suggestions on previous drafts of this manuscript.

Contributor Information

Karla D. Wagner, Division of Global Public Health, Department of Medicine, University of California San Diego

Jennifer B. Unger, Institute for Health Promotion and Disease Prevention Research; Keck School of Medicine, University of Southern California

Ricky N. Bluthenthal, Institute for Health Promotion and Disease Prevention Research; Keck School of Medicine, University of Southern California; Urban Community Research Center; Sociology Department; California State University Dominguez Hills; and Health Program and Drug Policy Research Center; RAND Corporation; Santa Monica, California.

Valentina A. Andreeva, U780 Cardiovascular Epidemiology, National Institute of Health and Medical Research (INSERM), Paris, France.

Mary Ann Pentz, Institute for Health Promotion and Disease Prevention Research; Keck School of Medicine, University of Southern California

VII. References

  1. Aceijas C, Stimson G, Hickman M, Rhodes T. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS. 2004;18:2295–2303. doi: 10.1097/00002030-200411190-00010. [DOI] [PubMed] [Google Scholar]
  2. Ajzen I. The theory of planned behavior. Organizational Behavior and Human Decision Processes. Special Issue: Theories of cognitive self-regulation. 1991;50(2):179–211. [Google Scholar]
  3. Avants SK, Margolin A, Usubiaga MH, Doebrick C. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: A randomized clinical trial of a harm reduction group therapy. Journal of Substance Abuse Treatment. 2004;26(67-78) doi: 10.1016/S0740-5472(03)00159-4. [DOI] [PubMed] [Google Scholar]
  4. Avants SK, Warburton LA, Hawkins KA, Margolin A. Continuation of high-risk behavior by HIV-positive drug users: Treatment implications. Journal of Substance Abuse Treatment. 2000;19(1):15. doi: 10.1016/s0740-5472(99)00092-6. [DOI] [PubMed] [Google Scholar]
  5. Bailey SL, Ouellet LJ, Mackesy-Amiti ME, Golub ET, Hagan H, Hudson SM, et al. Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young adult injection drug users in five U.S. Cities. Drug & Alcohol Dependence. 2007;91(Suppl 1):S39–47. doi: 10.1016/j.drugalcdep.2007.02.014. [DOI] [PubMed] [Google Scholar]
  6. Bandura A. Social foundations of thought and action: A Social Cognitive Theory. Prentice Hall; Englewood Cliffs, NJ: 1986. [Google Scholar]
  7. Bandura A. Health promotion by social cognitive means. Health Education & Behavior. 2004;31(2):143–164. doi: 10.1177/1090198104263660. [DOI] [PubMed] [Google Scholar]
  8. Baranowski T, Perry CL, Parcel GS. How individuals, environments, and health behavior interact. In: Glanz K, Lewis FM, Rimer BK, editors. Health behavior and health education: Theory, research, and practice. 2nd ed Jossey-Bass Publishers; San Francisco, California: 1997. pp. 153–178. [Google Scholar]
  9. Blankenship KM, Friedman SR, Dworkin S, Mantell JE. Structural interventions: Concepts, challenges, and opportunities for research. Journal of Urban Health. 2006;83(1):59–72. doi: 10.1007/s11524-005-9007-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bluthenthal RN, Anderson R, Flynn NM, Kral AH. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug and Alcohol Dependence. 2007;89(2-3):214–222. doi: 10.1016/j.drugalcdep.2006.12.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Booth RE. Predictors of unsafe needle practices: Injection drug users in denver. Journal of Acquired Immune Deficiency Syndromes. 1994;7(5):504–508. [PubMed] [Google Scholar]
  12. Booth RE, Kwiatkowski CF, Stephens RC. Effectiveness of HIV/AIDS interventions on drug use and needle risk behaviors for out-of-treatment injection drug users. Journal of Psychoactive Drugs. 1998;30(3):269–278. doi: 10.1080/02791072.1998.10399702. [DOI] [PubMed] [Google Scholar]
  13. Brown EJ. Female injecting drug users: Human Immunodeficiency Virus risk behavior and intervention needs. Journal of Professional Nursing. 1998;14(6):361–369. doi: 10.1016/s8755-7223(98)80078-1. [DOI] [PubMed] [Google Scholar]
  14. Burris S, Blankenship KM, Donoghoe M, Sherman S, Vernick JS, Case P, et al. Addressing the “Risk environment” for injection drug users: The mysterious case of the missing cop. Milbank Quarterly. 2004;82(1):125–156. doi: 10.1111/j.0887-378X.2004.00304.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Catania JA, Kegeles SM, Coates TJ. Towards an understanding of risk behavior: An AIDS Risk Reduction Model (ARRM) Health Education and Behavior. 1990;17(1):53–72. doi: 10.1177/109019819001700107. [DOI] [PubMed] [Google Scholar]
  16. Celentano DD, Cohn S, Davis RO, Vlahov D. Self-efficacy estimates for drug use practices predict risk reduction among injection drug users. Journal of Urban Health. 2002;79(2):245–256. doi: 10.1093/jurban/79.2.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Centers for Disease Control and Prevention Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR. 1998;47(No. RR-19) 1998. [PubMed] [Google Scholar]
  18. Centers for Disease Control and Prevention . HIV/AIDS surveillance report, 2005. Vol. 17. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; Atlanta, GA: [Retrieved April 12, 2007]. 2006. from http://www.cdc.gov/HIV/topics/surveillance/resources/reports/2005report/default.htm. [Google Scholar]
  19. Centers for Disease Control and Prevention HIV-associated behaviors among injecting-drug users -- 23 cities, United States, May 2005-February 2006. MMWR. 2009;58(13):329–332. [PubMed] [Google Scholar]
  20. Copenhaver MM, Johnson BT, Lee IC, Harman JJ, Carey MP, the SHARP Research Team Behavioral HIV risk reduction among people who inject drugs: Meta-analytic evidence of efficacy. Journal of Substance Abuse Treatment. 2006;31:163–171. doi: 10.1016/j.jsat.2006.04.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Copenhaver MM, Lee IC. Optimizing a community-friendly HIV risk reduction intervention for injection drug users in treatment: A structural equation modeling approach. Journal of Urban Health. 2006;83(6):1132–1142. doi: 10.1007/s11524-006-9090-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Copenhaver MM, Lee IC, Margolin A. Successfully integrating an HIV risk reduction intervention into a community-based substance abuse treatment program. The American Journal of Drug and Alcohol Abuse. 2007;33:109–120. doi: 10.1080/00952990601087463. [DOI] [PubMed] [Google Scholar]
  23. Cox J, De P, Morissette C, Tremblay C, Stephenson R, Allard R, et al. Low perceived benefits and self-efficacy are associated with hepatitis C virus (HCV) infection-related risk among injection drug users. Social Science & Medicine. 2008;66(2):211–220. doi: 10.1016/j.socscimed.2007.08.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Coyle SL, Needle RH, Normand J. Outreach-based HIV prevention for injecting drug users: A review of published outcome data. Public Health Reports. 1998;113(Suppl 1):19–30. [PMC free article] [PubMed] [Google Scholar]
  25. Davey-Rothwell MA, Latkin CA. Gender differences in social network influence among injection drug users: Perceived norms and needle sharing. Journal of Urban Health. 2007;84(5):691–703. doi: 10.1007/s11524-007-9215-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Des Jarlais DC, Braine N, Friedmann P. Unstable housing as a factor for increased injection risk behavior at us syringe exchange programs. AIDS and Behavior. 2007a;11(6 Suppl):78–84. doi: 10.1007/s10461-007-9227-6. [DOI] [PubMed] [Google Scholar]
  27. Des Jarlais DC, Braine N, Yi H, Turner C. Residual injection risk behavior, HIV infection, and the evaluation of syringe exchange programs. AIDS Education and Prevention. 2007b;19(2):111–123. doi: 10.1521/aeap.2007.19.2.111. [DOI] [PubMed] [Google Scholar]
  28. Des Jarlais DC, Perlis T, Arasteh K. “Informed altruism” and “Partner restriction” in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001. Journal of Acquired Immune Deficiency Syndromes. 2004;35(2):158–166. doi: 10.1097/00126334-200402010-00010. [DOI] [PubMed] [Google Scholar]
  29. Des Jarlais DC, Perlis T, Friedman SR, Chapman T, Kwok J, Rockwell R, et al. Behavioral risk reduction in a declining HIV epidemic: Injection drug users in New York City, 1990-1997. American Journal of Public Health. 2000;90(7):1112–1116. doi: 10.2105/ajph.90.7.1112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Des Jarlais DC, Semaan S. HIV prevention for injecting drug users: The first 25 years and counting. Psychosomatic Medicine. 2008;70(5):606–611. doi: 10.1097/PSY.0b013e3181772157. [DOI] [PubMed] [Google Scholar]
  31. Falck RS, Siegal HA, Wang J, Carlson RG. Usefulness of the Health Belief Model in predicting HIV needle risk practices among injection drug users. AIDS Education and Prevention. 1995;7(6):523–533. [PubMed] [Google Scholar]
  32. Fishbein M. The role of theory in HIV prevention. AIDS Care. 2000;12(3):273–278. doi: 10.1080/09540120050042918. [DOI] [PubMed] [Google Scholar]
  33. Fisher DG, Reynolds GL, Jaffe A, Johnson ME. Reliability, sensitivity and specificity of self-report of HIV test results. AIDS Care. 2007;19(5):692–696. doi: 10.1080/09540120601087004. [DOI] [PubMed] [Google Scholar]
  34. Fisher JD, Fisher WA. Changing AIDS-risk behavior. Psychological Bulletin. 1992;111(3):455–474. doi: 10.1037/0033-2909.111.3.455. [DOI] [PubMed] [Google Scholar]
  35. Friedman SR, Cooper H, Templaski B, Keem M, Friedman R, Flom PL, et al. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in us metropolitan areas. AIDS. 2006;20:93–99. doi: 10.1097/01.aids.0000196176.65551.a3. [DOI] [PubMed] [Google Scholar]
  36. Garfein RS, Golub ET, Greenberg A, Hagan H, Hanson DL, Hudson SM, et al. A peer-education intervention to reduce injection risk behaviors for HIV and HCV infection in young injection drug users. AIDS. 2007;21(14):1923–1932. doi: 10.1097/QAD.0b013e32823f9066. [DOI] [PubMed] [Google Scholar]
  37. Garfein RS, Monterroso ER, Tong TC, Vlahov D, Des Jarlais DC, Selwyn P, et al. Comparison of HIV infection risk behaviors among injection drug users from East and West coast US cities. J Urban Health. 2004;81(2):260–267. doi: 10.1093/jurban/jth112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Gibson DR, Choi KH, Catania JA, Sorensen JL, Kegeles S. Psychosocial predictors of needle sharing among intravenous drug users. International Journal of the Addictions. 1993;28(10):973–981. doi: 10.3109/10826089309062177. [DOI] [PubMed] [Google Scholar]
  39. Gibson DR, McCusker J, Chesney M. Effectiveness of psychosocial interventions in preventing HIV risk behaviour in injecting drug users. AIDS. 1998;12(8):919–929. doi: 10.1097/00002030-199808000-00015. [DOI] [PubMed] [Google Scholar]
  40. Glanz K, Lewis FM, Rimer B, editors. Health behavior and health education. 2nd ed Jossey-Bass; San Francisco: 1997. [Google Scholar]
  41. Hartgers C, Kriegler JA, Van der Pligt J. HIV and injecting drug users: The role of protection motivation. In: Hartgers C, editor. HIV risk behavior among injecting drug users in Amsterdam. Drugtext Foundation; Amsterdam: 1992. [Google Scholar]
  42. Hawkins WE, Latkin C, Mandel W, Oziemkowska M. Do actions speak louder than words? Perceived peer influences on needle sharing and cleaning in a sample of injection drug users. AIDS Education and Prevention. 1999;11(2):122–131. [PubMed] [Google Scholar]
  43. Jamner MS, Corby NH, Wolitski RJ. Bleaching injection equipment: Influencing factors among IDUs who share. Substance Use & Misuse. 1996;31(14):1973–1993. doi: 10.3109/10826089609066447. [DOI] [PubMed] [Google Scholar]
  44. Kang SY, Deren S, Andia J, Colon HM, Robles R. Effects of changes in perceived self-efficacy on HIV risk behaviors over time. Addictive Behaviors. 2004;29(3):567–574. doi: 10.1016/j.addbeh.2003.08.026. [DOI] [PubMed] [Google Scholar]
  45. Koester S, Glanz J, Baron A. Drug sharing among heroin networks: Implications for HIV and hepatitis B and C prevention. AIDS and Behavior. 2005;9(1):27–39. doi: 10.1007/s10461-005-1679-y. [DOI] [PubMed] [Google Scholar]
  46. Kowalewski M, Henson KD, Longshore D. Rethinking perceived risk and health behavior: A critical review of HIV prevention research. Health Education and Behavior. 1997;24(3):313–325. doi: 10.1177/109019819702400305. [DOI] [PubMed] [Google Scholar]
  47. Ksobiech K. A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders. AIDS Education and Prevention. 2003;15(3):257–268. doi: 10.1521/aeap.15.4.257.23828. [DOI] [PubMed] [Google Scholar]
  48. Latka MH, Hagan H, Kapadia F, Golub ET, Bonner S, Campbell JV, et al. A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C. American Journal of Public Health. 2008;98(5):853–861. doi: 10.2105/AJPH.2007.113415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Latkin CA, Vlahov D. Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users. Addiction. 1998;93(8):1191–1197. doi: 10.1046/j.1360-0443.1998.93811917.x. [DOI] [PubMed] [Google Scholar]
  50. Longshore D, Stein JA, Anglin MD. Psychosocial antecedents of needle/syringe disinfection by drug users: A theory-based prospective analysis. AIDS Education and Prevention. 1997;9(5):442–459. [PubMed] [Google Scholar]
  51. Longshore D, Stein JA, Conner BT. Psychosocial antecedents of injection risk reduction: A multivariate analysis. AIDS Education and Prevention. 2004;16(4):353–366. doi: 10.1521/aeap.16.4.353.40395. [DOI] [PubMed] [Google Scholar]
  52. MacDonald M, Law M, Kaldor J, Hales J, Dore GJ. Effectiveness of needle and syringe programmes for preventing HIV transmission. International Journal of Drug Policy. 2003;14(5-6):353–357. [Google Scholar]
  53. Margolin A, Avants SK, Warburton LA, Hawkins KA, Shi J. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychology. 2003;22(2):223–228. [PubMed] [Google Scholar]
  54. Martinez AN, Bluthenthal RN, Lorvick J, Anderson R, Flynn N, Kral AH. The impact of legalizing syringe exchange programs on arrests among injection drug users in California. Journal of Urban Health. 2007;84(3):423–435. doi: 10.1007/s11524-006-9139-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Mehta SH, Galai N, Astemborski J, Celentano DD, Strathdee SA, Vlahov D, et al. HIV incidence among injection drug users in Baltimore, Maryland (1988-2004) Journal of Acquired Immune Deficiency Syndromes. 2006;43(3):368–372. doi: 10.1097/01.qai.0000243050.27580.1a. [DOI] [PubMed] [Google Scholar]
  56. Metzger DS, Navaline H. HIV prevention among injection drug users: The need for integrated models. Journal of Urban Health. 2003;80(4, Suppl 3):iii59–iii66. doi: 10.1093/jurban/jtg083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Miller CL, Johnston C, Spittal PM, Li K, Laliberte N, Montaner JS, et al. Opportunities for prevention: Hepatitis c prevalence and incidence in a cohort of young injection drug users. Hepatology. 2002;36(3):737–742. doi: 10.1053/jhep.2002.35065. [DOI] [PubMed] [Google Scholar]
  58. Miller ER, Hellard ME, Bowden S, Bharadwaj M, Aitken CK. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia. Journal of Infection. 2009;58(5):375–382. doi: 10.1016/j.jinf.2009.02.014. [DOI] [PubMed] [Google Scholar]
  59. Needle RH, Coyle S, Cesari H, Trotter R, Clatts M, Koester S, et al. HIV risk behaviors associated with the injection process: Multiperson use of drug injection equipment and paraphernalia in injection drug user networks. Substance Use & Misuse. 1998;33(12):2403–2423. doi: 10.3109/10826089809059332. [DOI] [PubMed] [Google Scholar]
  60. Peters A, Davies T, Richardson A. Multi-site samples of injecting drug users in Edinburgh: Prevalence and correlates of risky injecting practices. Addiction. 1998;93(2):253–267. doi: 10.1046/j.1360-0443.1998.9322539.x. [DOI] [PubMed] [Google Scholar]
  61. Racz J, Gyarmathy VA, Neaigus A, Ujhelyi E. Injecting equipment sharing and perception of HIV and hepatitis risk among injecting drug users in Budapest. AIDS Care. 2007;19(1):59–66. doi: 10.1080/09540120600722742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Rhodes T. The ‘risk environment’: A framework for understanding and reducing drug-related harm. International Journal of Drug Policy. 2002;13:85–94. [Google Scholar]
  63. Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Social Science & Medicine. 2005;61(5):1026–1044. doi: 10.1016/j.socscimed.2004.12.024. [DOI] [PubMed] [Google Scholar]
  64. Robles RR, Cancel LI, Colon HM, Matos TD, Freeman DH, Sahai H. Prospective effects of perceived risk of developing HIV/AIDS on risk behaviors among injection drug users in Puerto Rico. Addiction. 1995;90:1105–1111. doi: 10.1046/j.1360-0443.1995.90811059.x. [DOI] [PubMed] [Google Scholar]
  65. Robles RR, Reyes JC, Colon HM, Sahai H, Marrero CA, Matos T. s. D., et al. Effects of combined counseling and case management to reduce HIV risk behaviors among Hispanic drug injectors in Puerto Rico: A randomized controlled study. Journal of Substance Abuse Treatment. 2004;27(2):145–152. doi: 10.1016/j.jsat.2004.06.004. [DOI] [PubMed] [Google Scholar]
  66. Rogers RW. Cognitive and physiological processes in fear appeals and attitude change: A revised theory of protection motivation. In: Cacioppo JT, Petty RE, editors. Social psychophysiology. The Guilford Press; New York: 1983. pp. 153–176. [Google Scholar]
  67. Saelim A, Geater A, Chongsuvivatwong V, Rodkla A, Bechtel GA. Needle sharing and high-risk sexual behaviors among iv drug users in southern Thailand. AIDS Patient Care STDS. 1998;12(9):707–713. doi: 10.1089/apc.1998.12.707. [DOI] [PubMed] [Google Scholar]
  68. Santibanez SS, Garfein RS, Swartzendruber A, Purcell DW, Paxton LA, Greenberg AE. Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. Journal of Urban Health. 2006;83(1):86–100. doi: 10.1007/s11524-005-9009-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Sarkar S, Panda S, Sarkar K, Hangzo CZ, Bijaya L, Singh NY, et al. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur. Indian Journal of Public Health. 1995;39(3):86–92. [PubMed] [Google Scholar]
  70. Smyth BP, Barry J, Keenan E. Syringe borrowing persists in Dublin despite harm reduction interventions. Addiction. 2001;96(5):717–727. doi: 10.1046/j.1360-0443.2001.9657177.x. [DOI] [PubMed] [Google Scholar]
  71. Smyth BP, Roche A. Recipient syringe sharing and its relationship to social proximity, perception of risk and preparedness to share. Addictive Behaviors. 2007;32(9):1943–1948. doi: 10.1016/j.addbeh.2006.12.021. Epub 2006 Dec 1922. [DOI] [PubMed] [Google Scholar]
  72. Sorensen JL, London J, Heitzmann C, Gibson DR, Morales ES, Dumontet R, et al. Psychoeducational group approach: HIV risk reduction in drug users. AIDS Education and Prevention. 1994;6(2):95–112. [PubMed] [Google Scholar]
  73. Stein MD, Dubyak P, Herman D, Anderson BJ. Perceived barriers to safe-injection practices among drug injectors who remain HCV-negative. The American Journal of Drug and Alcohol Abuse. 2007;33:517–525. doi: 10.1080/00952990701407298. [DOI] [PubMed] [Google Scholar]
  74. Strauss SM, Rindskopf DM, Deren S, Falkin GP. Concurrence of drug users’ self-report of current HIV status and serotest results. Journal of Acquired Immune Deficiency Syndromes. 2001;27(3):301–307. doi: 10.1097/00126334-200107010-00014. [DOI] [PubMed] [Google Scholar]
  75. Strecher VJ, Rosenstock IM. The Health Belief Model. In: Glanz K, Lewis FM, Timer BK, editors. Health behavior and health education: Theory, research, and practice. 2nd ed Jossey-Bass Publishers; San Francisco, California: 1997. pp. 41–59. [Google Scholar]
  76. Thiede H, Hagan H, Campbell JV, Strathdee SA, Bailey SL, Hudson SM, et al. Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. Cities. Drug & Alcohol Dependence. 2007;91(Suppl):S39–47. doi: 10.1016/j.drugalcdep.2007.03.001. [DOI] [PubMed] [Google Scholar]
  77. Tortu S, McMahon JM, Hamid R, Neaigus A. Women’s drug injection practices in East Harlem: An event analysis in a high-risk community. AIDS and Behavior. 2003;7(3):317–328. doi: 10.1023/a:1025452021307. [DOI] [PubMed] [Google Scholar]
  78. Wallston BS, Wallston KA. Social psychological models of health behavior: An examination and integration. In: Baum S, Taylor J, Singer E, editors. Handbook of psychology and health. volume IV: Social aspects of psychology (Vol. IV) Lawrence Erlbaum; Hillsdale, NJ: 1984. [Google Scholar]
  79. White JM, Dyer KR, Ali RL, Gaughwin MD, Cormack S. Injecting behaviour and risky needle use amongst methadone maintenance clients. Drug and Alcohol Dependence. 1994;34(2):113–119. doi: 10.1016/0376-8716(94)90131-7. [DOI] [PubMed] [Google Scholar]

RESOURCES